Peggy Barthel

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF Rat Model.

Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF Rat Model.

Journal: Circulation. Heart failure

Published: June 15, 2026

Mitochondrial Targeting by Elamipretide Improves Myocardial Bioenergetics Without Translating into Functional Benefits in HFpEF.

Mitochondrial Targeting by Elamipretide Improves Myocardial Bioenergetics Without Translating into Functional Benefits in HFpEF.

Journal: International journal of molecular sciences

Published: December 17, 2025

MyoMed205 Counteracts Titin Hyperphosphorylation and the Expression of Contraction-Regulating Proteins in a Rat Model of HFpEF.

MyoMed205 Counteracts Titin Hyperphosphorylation and the Expression of Contraction-Regulating Proteins in a Rat Model of HFpEF.

Journal: Journal of cachexia, sarcopenia and muscle

Published: January 21, 2025

Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain.

Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain.

Journal: Circulation. Heart failure

Published: June 07, 2024

Modulation of Titin and Contraction-Regulating Proteins in a Rat Model of Heart Failure with Preserved Ejection Fraction: Limb vs. Diaphragmatic Muscle.

Modulation of Titin and Contraction-Regulating Proteins in a Rat Model of Heart Failure with Preserved Ejection Fraction: Limb vs. Diaphragmatic Muscle.

Journal: International journal of molecular sciences

Published: May 24, 2024

Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF.

Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF.

Journal: Cells

Published: January 08, 2024

Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition.

Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition.

Journal: Cells

Published: September 20, 2023

Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model.

Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model.

Journal: International journal of molecular sciences

Published: August 08, 2022

Biocompatibility and Degradation Behavior of Molybdenum in an In Vivo Rat Model.

Biocompatibility and Degradation Behavior of Molybdenum in an In Vivo Rat Model.

Journal: Materials (Basel, Switzerland)

Published: November 16, 2021

Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility.

Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility.

Journal: Journal of cachexia, sarcopenia and muscle

Published: September 14, 2021

Sacubitril/Valsartan Improves Diastolic Function But Not Skeletal Muscle Function in a Rat Model of HFpEF.

Sacubitril/Valsartan Improves Diastolic Function But Not Skeletal Muscle Function in a Rat Model of HFpEF.

Journal: International journal of molecular sciences

Published: March 05, 2021

Frailty is associated with chronic inflammation and pro-inflammatory monocyte subpopulations.

Frailty is associated with chronic inflammation and pro-inflammatory monocyte subpopulations.

Journal: Experimental gerontology

Published: November 19, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026